Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (161-170 of 229) with videos related to

Pageof 23
Sort By:
The International Journal of Neuropsychopharmacology|November 6, 2016
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesKonstantinos N Fountoulakis, Allan Young, Lakshmi Yatham, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2020
Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin<sub>1A</sub> receptor neurotransmission in the hippocampusMostafa El Mansari, Mohammad Ebrahimzadeh, Rami Hamati, et al.
The International Journal of Neuropsychopharmacology|May 14, 2004
In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic systemNasser Haddjeri, Céline Faure, Guillaume Lucas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 14, 2013
Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controlsNatalia Jaworska, Elisea De Somma, Claude Blondeau, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 24, 2019
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depressionJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Focus (American Psychiatric Publishing)|December 21, 2020
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled TrialJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Frontiers in Psychiatry|April 17, 2024
One size does not fit all: notable individual variation in brain activity correlates of antidepressant treatment responseGwen van der Wijk, Yaruuna Enkhbold, Kelsey Cnudde, et al.
The American Journal of Psychiatry|March 30, 2019
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled TrialJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Biological Psychiatry|March 17, 2004
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorderNathan A Shapira, Herbert E Ward, Miguel Mandoki, et al.
BMC Medical Informatics and Decision Making|December 25, 2015
Data mining EEG signals in depression for their diagnostic valueMahdi Mohammadi, Fadwa Al-Azab, Bijan Raahemi, et al.
Pageof 23

Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
The International Journal of Neuropsychopharmacology|November 6, 2016
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of GuidelinesKonstantinos N Fountoulakis, Allan Young, Lakshmi Yatham, et al.
Journal of Psychopharmacology (Oxford, England)|July 21, 2020
Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin<sub>1A</sub> receptor neurotransmission in the hippocampusMostafa El Mansari, Mohammad Ebrahimzadeh, Rami Hamati, et al.
The International Journal of Neuropsychopharmacology|May 14, 2004
In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic systemNasser Haddjeri, Céline Faure, Guillaume Lucas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 14, 2013
Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controlsNatalia Jaworska, Elisea De Somma, Claude Blondeau, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 24, 2019
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depressionJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Focus (American Psychiatric Publishing)|December 21, 2020
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled TrialJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Frontiers in Psychiatry|April 17, 2024
One size does not fit all: notable individual variation in brain activity correlates of antidepressant treatment responseGwen van der Wijk, Yaruuna Enkhbold, Kelsey Cnudde, et al.
The American Journal of Psychiatry|March 30, 2019
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled TrialJennifer L Phillips, Sandhaya Norris, Jeanne Talbot, et al.
Biological Psychiatry|March 17, 2004
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorderNathan A Shapira, Herbert E Ward, Miguel Mandoki, et al.
BMC Medical Informatics and Decision Making|December 25, 2015
Data mining EEG signals in depression for their diagnostic valueMahdi Mohammadi, Fadwa Al-Azab, Bijan Raahemi, et al.
Pageof 23